US90184D1000
© BusinessWire
12.12.2025
TWST
LISTED
NASDAQ
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders.
If you currently own Twist stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to t...
Themefolio
Profiler
Peergroup
© BusinessWire
04.12.2025
TWST
LISTED
NASDAQ
Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade Plasmid DNA Preps designed to support the advancement of pharmaceutical and biotech customers’ pre-clinical studies.
“Our new plasmid preps combine the quality and consistency needed for preclinical research with the speed and co...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2025
TWST
LISTED
NASDAQ
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025 ended September 30, 2025.
Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
04.11.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will participate in a fireside chat at the at 7th Annual Wolfe Research Healthcare Conference on Monday, November 17, 2025 at 3:20 pm Eastern...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
03.11.2025
TWST
LISTED
NASDAQ
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that it has granted a total of 139,569 equity awards, consisting of 91,441 restricted stock units (“RSUs”) and up to 48,128 performance stock units (“PSUs”), to 41...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2025
TWST
LISTED
NASDAQ
Halper Sadeh LLC Encourages Twist Bioscience Corporation Shareholders to Contact the Firm to Discuss Their Rights
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to shareholders.
If you currently own Twist stock and acquired shares on or before December 20, 2018, you may be able to seek corporate governance reforms, the retur...
Themefolio
Profiler
Peergroup
© BusinessWire
23.10.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results on Friday, November 14, 2025
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for the fiscal 2025 fourth quarter and full year ended September 30, 2025, before the opening of the market on November 14, 2025. The company plans to hold a conference call and live audio webcast for an...
Themefolio
Profiler
Peergroup
© BusinessWire
06.10.2025
TWST
LISTED
NASDAQ
Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced the launch of Twist’s new Trinity Freestyle Fast Hybridization workflow for Element's AVITI™ sequencing platforms, a user-friendly, end-to-end seq...
Themefolio
Profiler
Peergroup
© BusinessWire
02.10.2025
TWST
LISTED
NASDAQ
Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced the publication in Science of the peer-reviewed paper, “Strengthening nucleic acid biosecurity screening against generative protein design tools,” led by Microsoft and co-authored with a consortium of scientific and industry experts including t...
Themefolio
Profiler
Peergroup
© BusinessWire
03.09.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Present at Baird 2025 Global Healthcare Conference
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird 2025 Global Healthcare Conference on Tuesday, September 9, 2025 at 9:40 am Eastern Time in New York City. The company will also host one-on-one mee...
Themefolio
Profiler
Peergroup
© BusinessWire
02.09.2025
TWST
LISTED
NASDAQ
Twist Bioscience Collaborates with Synthetic Design Lab
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has collaborated with next generation therapeutics company, Synthetic Design Lab (SDL).
“With our high throughput expertise, from novel binder discovery services to high throughput screening capabilities, we’re able to support researc...
Themefolio
Profiler
Peergroup
© BusinessWire
19.08.2025
TWST
LISTED
NASDAQ
Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity, in the life sciences segment of the health care sector, today launched the Twist Oncology DNA Comprehensive Genomic Profiling (CGP) Panel, a customizable, research-use-only solution designed to empower users to identify genomic alterations for a broad set of tumor...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
31.07.2025
TWST
LISTED
NASDAQ
Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced the launch of a humanized transgenic (HuTg) mouse model to expand and complement its offering of antibody discovery services and further streamline monoclonal antibody discovery.
“The...
Themefolio
Profiler
Peergroup
© BusinessWire
24.07.2025
TWST
LISTED
NASDAQ
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it has granted a total of 70,254 equity awards, consisting of 56,182 restricted stock units (“RSUs”)...
Themefolio
Profiler
Peergroup
© BusinessWire
14.07.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 third quarter ended June 30, 2025, before the opening of the market on August 4, 2025. The company plans to hold a conferenc...
Themefolio
Profiler
Peergroup
© BusinessWire
07.07.2025
TWST
LISTED
NASDAQ
Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today accelerated its Express turnaround time for all Twist Gene Fragments with a turnaround time starting at two business days for both adapters off and adaptors on configurations.
“We continue to i...
Themefolio
Profiler
Peergroup
© BusinessWire
22.05.2025
TWST
LISTED
NASDAQ
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced an expanded collaboration to enable Element’s AVITI systems and Trinity flowcells with...
Themefolio
Profiler
Peergroup
© BusinessWire
15.05.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Patrick Finn, Ph.D., president and COO of Twist Bioscience, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday June 3, 2025 at 10:00 am Central Time i...
Themefolio
Profiler
Peergroup
© BusinessWire
13.05.2025
TWST
LISTED
NASDAQ
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
News Preview
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it has granted a total of 72,991 equity awards, consisting of 53,600 restricted stock units (“RSUs”)...
Themefolio
Profiler
Peergroup
© BusinessWire
08.05.2025
TWST
LISTED
NASDAQ
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that the companies have entered into an updated collaboration renegotiated...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
TWST
LISTED
NASDAQ
Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the second quarter fiscal 2025 ended March 31, 2025.
Visit the Events and Presentations page of the Investor Relations section under the “...
Themefolio
Profiler
Peergroup
© BusinessWire
05.05.2025
TWST
LISTED
NASDAQ
Twist Bioscience Spins Out DNA Data Storage as Independent Company
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that the company has spun out its DNA data storage technology application as an independent company, named Atlas Data Storage (“Atlas”).
“There are many applications of synthetic DNA w...
Themefolio
Profiler
Peergroup
© BusinessWire
24.04.2025
TWST
LISTED
NASDAQ
Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced the expanded launch of the Twist High Throughput (HT) Unique Dual Index (UDI) Adapter System to enable multiplexing and sample batching at scale.
Indexing is a critical part of the lib...
Themefolio
Profiler
Peergroup
© BusinessWire
14.04.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 second quarter ended March 31, 2025, before the opening of the market on May 5, 2025. The company plans to hold a conference...
Themefolio
Profiler
Peergroup
© BusinessWire
31.03.2025
TWST
LISTED
NASDAQ
Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics software, today announced a collaboration to accelerate the adoption of NGS workflows in agricultural genomics (agrigenomics) by offering Twist’s FlexPrep™ Ult...
Themefolio
Profiler
Peergroup
© BusinessWire
11.03.2025
TWST
LISTED
NASDAQ
Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time, all Twist Express Genes orders placed by academic customers globally will be shipped in as few as four days* without incurring a premium for the rapid turnarou...
Themefolio
Profiler
Peergroup
© BusinessWire
25.02.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Present at Upcoming Investor Conferences
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:
Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis, CFO, will particip...
Themefolio
Profiler
Peergroup
© BusinessWire
19.02.2025
TWST
LISTED
NASDAQ
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it has granted a total of 123,024 equity awards, consisting of 72,394 restricted stock units (“RSUs”...
Themefolio
Profiler
Peergroup
© BusinessWire
03.02.2025
TWST
LISTED
NASDAQ
Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the first quarter fiscal 2025 ended December 31, 2024.
Visit the Events and Presentations page of the Investor Relations section under th...
Themefolio
Profiler
Peergroup
© BusinessWire
22.01.2025
TWST
LISTED
NASDAQ
Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial results for the fiscal 2025 first quarter ended December 31, 2024, before the opening of the market on February 3, 2025. The company plans to hold a con...
Themefolio
Profiler
Peergroup
© BusinessWire
19.12.2024
TWST
LISTED
NASDAQ
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 5:15 p.m. Pacific...
Themefolio
Profiler
Peergroup
© BusinessWire
18.11.2024
TWST
LISTED
NASDAQ
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the fourth quarter and full year fiscal 2024 ended September 30, 2024.
Visit the Events and Presentations page of the Investor Relations...
Themefolio
Profiler
Peergroup
© BusinessWire
14.11.2024
TWST
LISTED
NASDAQ
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the 7th Annual E...
Themefolio
Profiler
Peergroup
© BusinessWire
07.11.2024
TWST
LISTED
NASDAQ
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
News Preview
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 147,800 equity awards, consisting of 110,300 restricted st...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2024
TWST
LISTED
NASDAQ
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the FlexPrep™ Ultra-High Throughput Library Preparation Kit, designed with a proprietary Twist-developed enzyme to enable throughput at a low cost, and acc...
Themefolio
Profiler
Peergroup
© BusinessWire
24.10.2024
TWST
LISTED
NASDAQ
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 fourth quarter and full year ended September 30, 2024, before the opening of the market on November 18, 2024...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2024
TWST
LISTED
NASDAQ
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has entered into a royalty purchase agreement with XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator.
Under the terms of the agreement, XOMA Ro...
Themefolio
Profiler
Peergroup
© BusinessWire
15.10.2024
TWST
LISTED
NASDAQ
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Mike Fero, Ph.D., as chief information officer. Dr. Fero brings more than 30 years of experience leading startups, developing commercial software, res...
Themefolio
Profiler
Peergroup
© BusinessWire
12.09.2024
TWST
LISTED
NASDAQ
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that the U.S. Green Building Council (USGBC) awarded the company’s Wilsonville, OR facility LEED certification, meeting sustainability standards for its building, operat...
Themefolio
Profiler
Peergroup
© BusinessWire
09.09.2024
TWST
LISTED
NASDAQ
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today released its 2024 corporate responsibility report detailing Twist’s approach to sustainability, social responsibility and ethics. The report highlights Twist’s ongoing commitment...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2024
TWST
LISTED
NASDAQ
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
News Preview
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the Baird Global Healthcare Conference 2024 in New York City on Tuesday, September 10...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
